Position in VTRS
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$6,849
+$201 QoQ
Shares Held
507
-5.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Anfield Capital Management, LLC holds $9,625 across 6 Drug Manufacturers - Specialty & Generic names. VTRS ranks #1 (71.2% of the industry book) .
All Filings in VTRS
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,849 | 507 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $6,648 | 534 | Shares | Defined | 2026-02-03 | |
| 2025-09-30 | $5,019 | 507 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $4,527 | 507 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $4,415 | 507 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $6,312 | 507 | Shares | Defined | 2025-02-05 | |
| 2024-09-30 | $5,886 | 507 | Shares | Defined | 2024-11-08 | |
| 2024-06-30 | $5,389 | 507 | Shares | Defined | 2024-07-31 | |
| 2021-06-30 | $171 | 12 | Shares | Defined | 2021-08-03 | |
| No filing history on record for this holder in this stock. | ||||||